NCT07327073

Brief Summary

This study aimed to investigate the effects of high-intensity intermittent exercise and moderate-intensity continuous exercise on serum irisin levels, disease activity, functional status, and quality of life in patients with axial spondyloarthritis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jan 2026May 2026

First Submitted

Initial submission to the registry

December 25, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 8, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

January 30, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Expected
Last Updated

January 12, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 25, 2025

Last Update Submit

January 9, 2026

Conditions

Keywords

ankylosing spondylitisexerciseirisin

Outcome Measures

Primary Outcomes (1)

  • serum irisin level

    Blood samples will be taken from patients one day before the start of treatment, after a 12-hour fast, and again the morning after a 12-hour fast, immediately after the end of treatment. The collected blood samples will be centrifuged at 1500 g for 10 minutes to obtain serum. The obtained serum will be stored at -80°C until the day of the study. The aim of these serum samples is to determine the level of irisin.

    Before treatment and after treatment (week 8)

Secondary Outcomes (5)

  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    Before treatment, after treatment (week 8)

  • Ankylosing Spondylitis Activity Scoring-CRP (ASDAS-CRP)

    Before treatment, after treatment (week 8)

  • Bath Ankylosing Spondylitis Functional Index (BASFI)

    Before treatment, after treatment (week 8)

  • Bath Ankylosing Spondylitis Metrology Index (BASMI)

    Before treatment, after treatment (week 8)

  • Ankylosing Spondylitis Quality of Life Scale (ASQoL)

    Before treatment, after treatment (week 8)

Study Arms (3)

high-intensity exercise

EXPERIMENTAL

Patients in this group will receive information and education about their condition and will be instructed to continue their current medical treatment and attend follow-up appointments regularly. Additionally, this group will undergo a high-intensity interval training (HIIT) program with a physiotherapist for 40 sessions in total, 5 sessions per week for 8 weeks, each lasting 35 minutes. Patients will work at 80% to 100% of their maximum heart rate. The first 4 weeks will be at 80% of maximum heart rate, followed by 85%, 90%, 95%, and finally 100%. This protocol will consist of 4 active periods of 4 minutes each at 80% to 100% of maximum heart rate (percentage to be determined weekly) and 3 rest periods of 3 minutes each at 60-70% of maximum heart rate (4x4 minutes). Each session will include a 5-minute warm-up before HIIT and a 5-minute cool-down after HIIT, for a total exercise time of 35 minutes.

Other: High-Intensity Interval Training

moderate intensity exercise

EXPERIMENTAL

Patients in this group will receive information and education about their condition and will be instructed to continue their current medical treatment and attend regular follow-up appointments. Additionally, these patients will undergo a 40-minute, 5-session, 40-minute moderate-intensity continuous exercise (MCIT) program with a physiotherapist over 8 weeks. Patients will exercise at 50-70% of their maximum heart rate and with an RPE of 11-13 for 30 minutes. Each session will include a 5-minute warm-up before MCIT and a 5-minute cool-down after MCIT, for a total exercise duration of 40 minutes.

Other: Moderate-Intensity Continuous Exercise

control

ACTIVE COMPARATOR

Patients in this group will receive information and education about their illness and will be advised to continue their current medical treatment and attend their follow-up appointments regularly.

Other: control group

Interventions

Patients will be trained at 80% to 100% of their maximum heart rate. For the first 4 weeks, they will train at 80% of their maximum heart rate, then at 85%, 90%, 95%, and finally 100%. This protocol will consist of 4 active periods of 4 minutes each at 80% to 100% of maximum heart rate (percentage to be determined weekly) and 3 rest periods of 3 minutes each at 60-70% of maximum heart rate (4x4 minutes). Each session will include a 5-minute warm-up before HIIT and a 5-minute cool-down after HIIT, for a total exercise time of 35 minutes.

high-intensity exercise

Patients will be trained for 30 minutes at 50% to 70% of their maximum heart rate and with an RPE of 11-13. Each session will include a 5-minute warm-up before MCIT and a 5-minute cool-down after MCIT, for a total exercise time of 40 minutes.

moderate intensity exercise

They will be given information and education about their illnesses and will be advised to continue their current medical treatment and attend their follow-up appointments regularly.

control

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients diagnosed with axillary spondyloarthropathy according to ASAS diagnostic criteria,
  • Having a high disease severity (ASDAS-CRP above 2.1),
  • Being sedentary (not engaging in physical activity at least 3 days a week in the last 3 months),
  • Having no change in ankylosing spondylitis medical treatment in the last 3 months,
  • Not having any orthopedic, neurological, cardiovascular, or mental disease that would affect exercise,
  • Not using any assistive devices for ambulation,
  • Having a BMI of 25 kg/m2 or less,
  • Male and female patients aged 18-50 years.

You may not qualify if:

  • Those with uncontrolled cardiopulmonary disease (such as hypertension, chronic obstructive pulmonary disease, heart failure),
  • Having comorbidities that reduce exercise capacity,
  • Pregnancy,
  • Malignancy,
  • Those with a recent history of surgery,
  • Those who have engaged in regular exercise (aquatic exercise, land exercise, etc.) in the previous 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırşehir Ahi Evran Üniversitesi

Kırşehir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Spondylitis, AnkylosingMotor Activity

Interventions

High-Intensity Interval TrainingControl Groups

Condition Hierarchy (Ancestors)

Axial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritisBehavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Nazife Kapan Tunçer Asst. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

December 25, 2025

First Posted

January 8, 2026

Study Start

January 30, 2026

Primary Completion

April 30, 2026

Study Completion (Estimated)

May 30, 2026

Last Updated

January 12, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations